These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11071087)
21. Achondroplasia in Sweden caused by the G1138A mutation in FGFR3. Alderborn A; Anvret M; Gustavson KH; Hagenäs L; Wadelius C Acta Paediatr; 1996 Dec; 85(12):1506-7. PubMed ID: 9001669 [TBL] [Abstract][Full Text] [Related]
22. Mutations in short stature homeobox containing gene (SHOX) in dyschondrosteosis but not in hypochondroplasia. Grigelioniene G; Eklöf O; Ivarsson SA; Westphal O; Neumeyer L; Kedra D; Dumanski J; Hagenäs L Hum Genet; 2000 Aug; 107(2):145-9. PubMed ID: 11030412 [TBL] [Abstract][Full Text] [Related]
23. Analysis of the FGFR3 gene in Japanese patients with achondroplasia and hypochondroplasia. Katsumata N; Mikami S; Nagashima-Miyokawa A; Nimura A; Sato N; Horikawa R; Tanae A; Tanaka T Endocr J; 2000 Mar; 47 Suppl():S121-4. PubMed ID: 10890199 [TBL] [Abstract][Full Text] [Related]
24. FGFR3 gene mutations in transmembrane domain in Chinese achondroplasia and hypochondroplasia patients. Yan-Ling G; Ji-Hong N; Guo-Qiang L; Wei W; De-Fen W Horm Res; 1998; 49 Suppl 1():57. PubMed ID: 9554479 [No Abstract] [Full Text] [Related]
25. Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype. Camera G; Baldi M; Strisciuglio G; Concolino D; Mastroiacovo P; Baffico M Am J Med Genet; 2001 Dec; 104(4):277-81. PubMed ID: 11754059 [TBL] [Abstract][Full Text] [Related]
26. [Mutations of FGFR3 gene cause 3 types of nanisms with variably severity: achondroplasia, thanatophoric nanism and hypochondroplasia]. Rousseau F; Bonaventure J; Le Merrer M; Maroteaux P; Munnich A Ann Endocrinol (Paris); 1996; 57(3):153. PubMed ID: 8949408 [No Abstract] [Full Text] [Related]
27. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Li C; Chen L; Iwata T; Kitagawa M; Fu XY; Deng CX Hum Mol Genet; 1999 Jan; 8(1):35-44. PubMed ID: 9887329 [TBL] [Abstract][Full Text] [Related]
28. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Bellus GA; Hefferon TW; Ortiz de Luna RI; Hecht JT; Horton WA; Machado M; Kaitila I; McIntosh I; Francomano CA Am J Hum Genet; 1995 Feb; 56(2):368-73. PubMed ID: 7847369 [TBL] [Abstract][Full Text] [Related]
29. p.Ser348Cys mutation in FGFR3 gene leads to "Mild ACH /Severe HCH" phenotype. Bengur FB; Ekmekci CG; Karaarslan E; Gunoz H; Alanay Y Eur J Med Genet; 2020 Feb; 63(2):103659. PubMed ID: 31048079 [TBL] [Abstract][Full Text] [Related]
30. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Naski MC; Wang Q; Xu J; Ornitz DM Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234 [TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor receptor 3 and the human chondrodysplasias. Horton WA Curr Opin Pediatr; 1997 Aug; 9(4):437-42. PubMed ID: 9300204 [TBL] [Abstract][Full Text] [Related]
33. Clinical and radiographic features of a family with hypochondroplasia owing to a novel Asn540Ser mutation in the fibroblast growth factor receptor 3 gene. Mortier G; Nuytinck L; Craen M; Renard JP; Leroy JG; de Paepe A J Med Genet; 2000 Mar; 37(3):220-4. PubMed ID: 10777366 [No Abstract] [Full Text] [Related]
34. Molecularly proven hypochondroplasia with cloverleaf skull deformity: a novel association. Angle B; Hersh JH; Christensen KM Clin Genet; 1998 Nov; 54(5):417-20. PubMed ID: 9842995 [TBL] [Abstract][Full Text] [Related]
35. Compound heterozygosity for the Achondroplasia-hypochondroplasia FGFR3 mutations: prenatal diagnosis and postnatal outcome. Chitayat D; Fernandez B; Gardner A; Moore L; Glance P; Dunn M; Chun K; Sgro M; Ray P; Allingham-Hawkins D Am J Med Genet; 1999 Jun; 84(5):401-5. PubMed ID: 10360393 [TBL] [Abstract][Full Text] [Related]
36. FGFR3 gene mutation (Gly380Arg) with achondroplasia and i(21q) Down syndrome: phenotype-genotype correlation. Chen H; Mu X; Sonoda T; Kim KC; Dailey K; Martinez J; Tuck-Muller C; Wertelecki W South Med J; 2000 Jun; 93(6):622-4. PubMed ID: 10881785 [TBL] [Abstract][Full Text] [Related]
37. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor]. van Ravenswaaij-Arts CM; Losekoot M Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167 [TBL] [Abstract][Full Text] [Related]
38. Clinical and Radiologic Evaluation of an Individual with Hypochondroplasia and a Novel FGFR3 Mutation. Ramos Mejía R; Aza-Carmona M; Del Pino M; Heath KE; Fano V; Obregon MG J Pediatr Genet; 2020 Mar; 9(1):48-52. PubMed ID: 31976144 [TBL] [Abstract][Full Text] [Related]
39. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses. Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057 [TBL] [Abstract][Full Text] [Related]
40. Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia. Tonoki H; Nakae J; Tajima T; Shinohara N; Monji J; Satoh S; Fujieda K Jpn J Hum Genet; 1995 Dec; 40(4):347-9. PubMed ID: 8851771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]